$0.00
(0.00%
) Quote details
USD
( 0.00%
At Close (As of Jan 1, 1970)
$4.89B
Market Cap
11.13
P/E Ratio
2.77
EPS
$46.48
52 Week High
$25.28
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
TG Therapeutics, Inc. (TGTX) is a prominent biopharmaceutical company based in New York, specializing in the development and commercialization of targeted therapies for B-cell malignancies and autoimmune diseases. With a robust pipeline of innovative product candidates, the company leverages advanced drug development technologies, positioning itself as a leader in the oncology and autoimmune treatment landscape. Committed to addressing significant unmet medical needs, TG Therapeutics focuses on enhancing patient outcomes through its precision medicine strategies and extensive clinical development programs.
LPTX
NVDA
WBD
ASST
VHAI
PLUG
BYND
AAL
TSLA
INTC
SOFI
CFLT
NFLX
ADAP
GRAB
BITF
BAC
PFE
MARA
T
DNN
KVUE
IRBT
WULF
CIFR
F
CLSK
KEY
VZ
APLD
HPE
RGTI
CXAI
IREN
GOOGL
HBAN
NIO
BTBT
MTSR
DVLT
RIG
AMD
RR
SOUN
MSTR
XOM
AVGO
SNAP
WMT
MRVL
VALE
QBTS
KDP
CAN
ITUB
SLM
NVTS
AGNC
NCLH
HOOD
PCG
LPTX
NVDA
WBD
ASST
VHAI
PLUG
BYND
AAL
TSLA
INTC
SOFI
CFLT
NFLX
ADAP
GRAB
BITF
BAC
PFE
MARA
T
DNN
KVUE
IRBT
WULF
CIFR
F
CLSK
KEY
VZ
APLD
HPE
RGTI
CXAI
IREN
GOOGL
HBAN
NIO
BTBT
MTSR
DVLT
RIG
AMD
RR
SOUN
MSTR
XOM
AVGO
SNAP
WMT
MRVL
VALE
QBTS
KDP
CAN
ITUB
SLM
NVTS
AGNC
NCLH
HOOD
PCG